“Therefore, those two charges are dismissed.”
He also ordered Mangione to return to court on December 1 for a hearing to discuss the handling of evidence in the case.
Fervent supporters of Mangione gathered both inside and outside court to show their backing for the 27-year-old whose alleged crimes have sharply divided Americans.
Thompson’s murder brought to the surface deep public frustration with the lucrative US commercial health care system, with some social media users painting Mangione as a hero.
He is charged in both state and federal court in the December 4 shooting of Thompson, who was chief executive of UnitedHealthcare.
Insufficient evidence for ‘terrorism’
If convicted in the state case, Mangione could face life imprisonment with no parole. In the federal case, he could technically face the death penalty.
One of the protesters, who were mostly young women, held up an Italian flag emblazoned with the words “healthcare is a human right”.
Mangione’s attorney, Karen Friedman Agnifilo, has sought clarity on how simultaneous federal and state charges would work, calling the situation “highly unusual.”
Dozens of Mangione’s supporters chased his legal team along the street after they left court following the packed hearing.
Mangione was arrested in Altoona, Pennsylvania, on December 9 following a tip from staff at a McDonald’s restaurant, after a days-long manhunt.
He had travelled to New York by bus from Atlanta about 10 days before the crime, US prosecutors said.
After checking into a Manhattan hostel with false identification, he allegedly performed reconnaissance near the victim’s hotel and the conference venue where the shooting took place.
Early on December 4, Mangione allegedly tracked Thompson, walked up behind him and fired several gunshots from a pistol with a silencer, federal prosecutors said. Afterward, he is said to have fled on a bicycle.
- AFP
Sign up to Herald Premium Editor’s Picks, delivered straight to your inbox every Friday. Editor-in-Chief Murray Kirkness picks the week’s best features, interviews and investigations. Sign up for Herald Premium here.